115 related articles for article (PubMed ID: 18855536)
21. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
22. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin.
Marques-Vidal P; Bongard V; Ruidavets JB; Fauvel J; Hanaire-Broutin H; Perret B; Ferrières J
Obes Res; 2003 Oct; 11(10):1200-6. PubMed ID: 14569045
[TBL] [Abstract][Full Text] [Related]
23. [Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease].
Lee DM; Lee SO; Mun BS; Ahn HS; Park HY; Lee HS; Kim DG
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):355-62. PubMed ID: 12506239
[TBL] [Abstract][Full Text] [Related]
24. Influence of birth weight on the apo E genetic determinants of plasma lipid levels in children.
Garcés C; Benavente M; Ortega H; Rubio R; Lasunción MA; Rodríguez Artalejo F; Fernandez Pardo J; de Oya M
Pediatr Res; 2002 Dec; 52(6):873-8. PubMed ID: 12438664
[TBL] [Abstract][Full Text] [Related]
25. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
[TBL] [Abstract][Full Text] [Related]
26. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects.
Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z
Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Anoop S; Misra A; Meena K; Luthra K
Indian J Med Res; 2010 Oct; 132():363-78. PubMed ID: 20966513
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E gene polymorphisms in Lebanese with hypercholesterolemia.
Mahfouz RA; Charafeddine KM; Tanios RF; Karaky NM; Abdul Khalik RN; Daher RT
Gene; 2013 Jun; 522(1):84-8. PubMed ID: 23537987
[TBL] [Abstract][Full Text] [Related]
29. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D; Zorc M; Peterlin B
Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
Liberopoulos E; Miltiadous G; Hatzivassiliou M; Ayrton N; Bairaktari E; Cariolou M; Elisaf M
Ann Clin Lab Sci; 2004; 34(3):347-54. PubMed ID: 15487712
[TBL] [Abstract][Full Text] [Related]
31. Association between apolipoprotein E gene polymorphism and the dose for warfarin maintenance.
Huang S; Chen B; Xiang D; Huang L; An B; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):212-6. PubMed ID: 21464541
[TBL] [Abstract][Full Text] [Related]
32. [Meta-analysis for relationship between apoE gene polymorphism and coronary heart disease].
Wang CH; Zhou X
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):368-70. PubMed ID: 14680604
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
34. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
35. Relation of apolipoprotein E polymorphism to lipid metabolism in obese children.
Parlier G; Thomas G; Bereziat G; Fontaine JL; Girardet JP
Pediatr Res; 1997 May; 41(5):682-5. PubMed ID: 9128291
[TBL] [Abstract][Full Text] [Related]
36. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran.
Kharrazi H; Vaisi Raygani A; Sabokroh AR; Pourmotabbed T
Clin Biochem; 2006 Jun; 39(6):613-6. PubMed ID: 16545358
[TBL] [Abstract][Full Text] [Related]
37. The APOE locus and the pharmacogenetics of lipid response.
Ordovas JM; Mooser V
Curr Opin Lipidol; 2002 Apr; 13(2):113-7. PubMed ID: 11891412
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group.
Bednarska-Makaruk M; Broda G; Kurjata P; Rodo M; Roszczynko M; Rywik S; Wehr H
Eur J Epidemiol; 2001; 17(8):789-92. PubMed ID: 12086099
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease.
Singh PP; Singh M; Bhatnagar DP; Kaur TP; Gaur SK
Indian J Med Sci; 2008 Mar; 62(3):105-12. PubMed ID: 18376083
[TBL] [Abstract][Full Text] [Related]
40. Mediation of the APOE associations with Alzheimer's and coronary heart diseases through body mass index and lipids.
Loika Y; Feng F; Loiko E; Kulminski AM
Geroscience; 2022 Apr; 44(2):1141-1156. PubMed ID: 34554385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
